Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
13.34
+0.07 (0.53%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Pharming Group Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Pharming Group stock have an average target of 38, with a low estimate of 37 and a high estimate of 40. The average target predicts an increase of 184.86% from the current stock price of 13.34.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pharming Group stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $37 | Buy | Maintains | $37 | +177.36% | Jun 23, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $37 | Buy | Reiterates | $37 | +177.36% | Jun 4, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $41 → $40 | Buy | Maintains | $41 → $40 | +199.85% | May 8, 2026 |
Financial Forecast
Revenue This Year
403.53M
from 376.13M
Increased by 7.28%
Revenue Next Year
447.80M
from 403.53M
Increased by 10.97%
EPS This Year
0.03
from 0.00
Increased by 669.25%
EPS Next Year
0.04
from 0.03
Increased by 17.68%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 412.9M | 531.2M | |
| Avg | 403.5M | 447.8M | |
| Low | 390.1M | 415.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.8% | 31.6% | |
| Avg | 7.3% | 11.0% | |
| Low | 3.7% | 3.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.05 | 0.08 | |
| Avg | 0.03 | 0.04 | |
| Low | 0.01 | -0.01 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,188.5% | 167.9% | |
| Avg | 669.3% | 17.7% | |
| Low | 150.0% | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.